Evidence mapPaperPMID 37599389Full record

ArticleJournal of diabetes science and technology2023

Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.

Guido Freckmann, Manuel Eichenlaub, Delia Waldenmaier, Stefan Pleus, Stephanie Wehrstedt, Cornelia Haug, Lilian Witthauer, Johan Jendle, Rolf Hinzmann, Andreas Thomas and 7 more

Abstract readScoping Review
In one paragraph

Article in Journal of diabetes science and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Performance of a New Continuous Glucose Monitoring System in German Adults Living with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Accuracy and Reliability of the Sinocare Continuous Glucose Monitoring System.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Guido FreckmannIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0002-0406-9529
Manuel EichenlaubInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.ORCID 0000-0003-2150-3160
Delia WaldenmaierInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.ORCID 0000-0003-3280-2369
Stefan PleusInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.ORCID 0000-0003-4629-7754
Stephanie WehrstedtInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Cornelia HaugInstitut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.
Lilian WitthauerDiabetes Center Berne, Bern, Switzerland.ORCID 0000-0001-9459-875X
Johan JendleIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0003-1025-1682
Rolf HinzmannIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0002-8419-4740
Andreas ThomasIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0002-6549-2793
Elisabet Eriksson BoijaIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.
Konstantinos MakrisIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0002-7896-9028
Peter DiemIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.
Nam TranIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0003-1565-0025
David C KlonoffIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0001-6394-6862
James H NicholsIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.ORCID 0000-0002-3652-1612
Robbert J SlingerlandIFCC Scientific Division - Working Group on Continuous Glucose Monitoring.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of different approaches for design and results presentation of studies for the clinical performance evaluation of continuous glucose monitoring (CGM) systems has long been recognized as a major challenge in comparing their results. However, a comprehensive characterization of the variability in study designs is currently unavailable. This article presents a scoping review of clinical CGM performance evaluations published between 2002 and 2022. Specifically, this review quantifies the prevalence of numerous options associated with various aspects of study design, including subject population, comparator (reference) method selection, testing procedures, and statistical accuracy evaluation. We found that there is a large variability in nearly all of those aspects and, in particular, in the characteristics of the comparator measurements. Furthermore, these characteristics as well as other crucial aspects of study design are often not reported in sufficient detail to allow an informed interpretation of study results. We therefore provide recommendations for reporting the general study design, CGM system use, comparator measurement approach, testing procedures, and data analysis/statistical performance evaluation. Additionally, this review aims to serve as a foundation for the development of a standardized CGM performance evaluation procedure, thereby supporting the goals and objectives of the Working Group on CGM established by the Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine.

Indexed as

Blood GlucoseDiabetes Mellitus, Type 1Blood Glucose Self-MonitoringHumansBlood Glucoseaccuracyclinical performance evaluationcontinuous glucose monitoringstudy design

Identifiers

PMID37599389
PMCPMC10658695

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.